Yuriy A. Kim
Yuriy A. Kim has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Dmitrii Yu. Pushkar
Russian University of Medicine, Ministry of Health of Russia; S. P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department
9 shared publications - Alexander O. Vasilyev
Russian University of Medicine, Ministry of Health of Russia
8 shared publications - Alexander V. Govorov
Russian University of Medicine, Ministry of Health of Russia
7 shared publications - Pavel A. Arutyunyan
Research Institute for Healthcare Organization and Medical Management, Moscow Healthcare Department; S. P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department
3 shared publications - Arseniy A. Shiryaev
Yevdokimov Moscow State University of Medicine and Dentistry; Spasokukotsky City Clinical Hospital
2 shared publications - Igor O. Gritskov
Russian University of Medicine
2 shared publications
Latest Publications
- Open Access
- 25 June 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (2)
Chatbots based on artificial intelligence in oncourology: assessment of the reliability and quality of medical information.
Introduction. In the era of digital progress and the development of artificial intelligence (AI) technologies, the potential application of chatbots in various fields, including medicine, has gained significant attention. With the global accessibility of the internet and the growing popularity of such services, there is an increasing need to evaluate the reliability and quality of the data generated, particularly concerning malignant neoplasms. The aim of this study was to analyze the quality of medical information related to prostate and bladder cancer using AI-based chatbots. Materials and methods. A study was conducted involving the examination and analysis of web traffic data from StatCounter. Based on the results of the web analysis to determine the leading search engine in overall web traffic in Russia, we used data from the Yandex Wordstat analytics service. We also conducted an assessment of responses from four AI-based chatbots to the most in-demand medical queries related to the two urological cancers with the highest incidence rates-prostate cancer and bladder cancer. We used publicly available versions of the four AI-based chatbots: ChatGPT, Perplexity, YaGPT, and GigaChat. To evaluate the quality of the medical information provided by the chatbots, we applied the validated DIS- CERN assessment tool. In addition, qualitative analysis and expert evaluation using DISCERN were carried out with the participation of 50 respondents-oncourologists with at least 10 years of professional experience in Russia. Results. We obtained and analyzed the evaluation results using the DISCERN scale. The highest overall score for medical information quality was achieved by the Perplexity chatbot, followed by ChatGPT in second place, and GigaChat in third. YaGPT ranked fourth and last. It is worth noting that all chatbots, to varying degrees, made errors and inaccuracies in generating medical information in response to the relevant queries. Conclusion. Today, AI-based chatbots represent a promising and in-demand direction. With the advancement of technology and the widespread adoption of software solutions, more people are turning to such services in search of authoritative medical information. However, at this stage, not all chatbots are capable of providing accurate medical content. Further development of AI architecture and internal algorithms is required, as well as the creation of standards and recommendations for integrating chatbots into medical information systems. This will help shape the direction of AI solutions for the coming decades and support both physicians and patients in diagnostics and decision-making.
- 25 June 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (2)
Open AccessChatbots based on artificial intelligence in oncourology: assessment of the reliability and quality of medical information.
Introduction. In the era of digital progress and the development of artificial intelligence (AI) technologies, the potential application of chatbots in various fields, including medicine, has gained significant attention. With the global accessibility of the internet and the growing popularity of such services, there is an increasing need to evaluate the reliability and quality of the data generated, particularly concerning malignant neoplasms. The aim of this study was to analyze the quality of medical information related to prostate and bladder cancer using AI-based chatbots. Materials and methods. A study was conducted involving the examination and analysis of web traffic data from StatCounter. Based on the results of the web analysis to determine the leading search engine in overall web traffic in Russia, we used data from the Yandex Wordstat analytics service. We also conducted an assessment of responses from four AI-based chatbots to the most in-demand medical queries related to the two urological cancers with the highest incidence rates-prostate cancer and bladder cancer. We used publicly available versions of the four AI-based chatbots: ChatGPT, Perplexity, YaGPT, and GigaChat. To evaluate the quality of the medical information provided by the chatbots, we applied the validated DIS- CERN assessment tool. In addition, qualitative analysis and expert evaluation using DISCERN were carried out with the participation of 50 respondents-oncourologists with at least 10 years of professional experience in Russia. Results. We obtained and analyzed the evaluation results using the DISCERN scale. The highest overall score for medical information quality was achieved by the Perplexity chatbot, followed by ChatGPT in second place, and GigaChat in third. YaGPT ranked fourth and last. It is worth noting that all chatbots, to varying degrees, made errors and inaccuracies in generating medical information in response to the relevant queries. Conclusion. Today, AI-based chatbots represent a promising and in-demand direction. With the advancement of technology and the widespread adoption of software solutions, more people are turning to such services in search of authoritative medical information. However, at this stage, not all chatbots are capable of providing accurate medical content. Further development of AI architecture and internal algorithms is required, as well as the creation of standards and recommendations for integrating chatbots into medical information systems. This will help shape the direction of AI solutions for the coming decades and support both physicians and patients in diagnostics and decision-making.
- Open Access
- 25 March 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (1)
Artificial intelligence in early diagnosis of prostate cancer.
Introduction. To assess the prospects of using artificial intelligence (AI) for the diagnosis and treatment of prostate cancer (PCa) and to evaluate the impact of AI on treatment efficacy. Materials and Methods. A systematic literature review was conducted using scientific databases based on key queries related to AI and PCa. Studies from the last 10 years were included. Results. AI algorithms, such as machine learning (ML) and deep learning (DL), improve the quality of PCa diagnostics, minimize subjective factors, and optimize the diagnostic process. The implementation of computer-aided detection (CAD) systems also enhances diagnostic accuracy, while the results depend on the expertise of specialists. Discussion. AI-based systems have the potential to improve diagnostics, personalize treatment, and reduce healthcare costs. However, issues related to the quality of AI training data and the interpretation of algorithms require further investigation. Conclusions. The use of AI in PCa diagnostics is a promising direction. However, additional research is needed for a comprehensive assessment of effective systems and the implementation process.
- 25 March 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (1)
Open AccessArtificial intelligence in early diagnosis of prostate cancer.
Introduction. To assess the prospects of using artificial intelligence (AI) for the diagnosis and treatment of prostate cancer (PCa) and to evaluate the impact of AI on treatment efficacy. Materials and Methods. A systematic literature review was conducted using scientific databases based on key queries related to AI and PCa. Studies from the last 10 years were included. Results. AI algorithms, such as machine learning (ML) and deep learning (DL), improve the quality of PCa diagnostics, minimize subjective factors, and optimize the diagnostic process. The implementation of computer-aided detection (CAD) systems also enhances diagnostic accuracy, while the results depend on the expertise of specialists. Discussion. AI-based systems have the potential to improve diagnostics, personalize treatment, and reduce healthcare costs. However, issues related to the quality of AI training data and the interpretation of algorithms require further investigation. Conclusions. The use of AI in PCa diagnostics is a promising direction. However, additional research is needed for a comprehensive assessment of effective systems and the implementation process.
- Open Access
- 22 November 2024
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 20 (3) , 159-167
Decision support systems in the diagnosis of urological diseases
The need to process large amounts of data has led to the creation of software that can improve and facilitate the work of medical staff. Decision support systems (DSS) are now used in many branches of medicine both at the outpatient and inpatient stages of medical care, helping clinicians to choose the tactics of treatment and management of each individual patient. These systems to a certain extent can improve treatment results and diagnostic process. The introduction of DSS in clinical practice has shown many advantages in reducing the frequency of misdiagnosis and, consequently, the risk of medical errors. At the same time, DSS can have a number of disadvantages. For example, physicians may view them as a threat to their “clinical autonomy”, and the implementation and subsequent maintenance of DSS can be quite costly. Artificial intelligence, which is increasingly being used not only for diagnosis, but also for treatment and prediction of outcomes in various diseases, should be considered as a prerequisite for the creation of DSS. Active development of artificial intelligence has been noted in almost all branches of medicine. A non-systematic review of the available literature published in the period between 2012 and 2022 has shown that the application of AI in prostate cancer diagnosis has great potential in clinical practice, as it helps both in the choice of treatment method and in planning the course of further surgery.
- 22 November 2024
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 20 (3) , 159-167
Open AccessDecision support systems in the diagnosis of urological diseases
The need to process large amounts of data has led to the creation of software that can improve and facilitate the work of medical staff. Decision support systems (DSS) are now used in many branches of medicine both at the outpatient and inpatient stages of medical care, helping clinicians to choose the tactics of treatment and management of each individual patient. These systems to a certain extent can improve treatment results and diagnostic process. The introduction of DSS in clinical practice has shown many advantages in reducing the frequency of misdiagnosis and, consequently, the risk of medical errors. At the same time, DSS can have a number of disadvantages. For example, physicians may view them as a threat to their “clinical autonomy”, and the implementation and subsequent maintenance of DSS can be quite costly. Artificial intelligence, which is increasingly being used not only for diagnosis, but also for treatment and prediction of outcomes in various diseases, should be considered as a prerequisite for the creation of DSS. Active development of artificial intelligence has been noted in almost all branches of medicine. A non-systematic review of the available literature published in the period between 2012 and 2022 has shown that the application of AI in prostate cancer diagnosis has great potential in clinical practice, as it helps both in the choice of treatment method and in planning the course of further surgery.
- Open Access
- 25 March 2024
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 17 (1)
Moscow program on histofusion biopsy of the prostate: results of a survey of practicing urologists based on data from a multicenter study.
Introduction. Prostate cancer (PC) is one of the most frequently diagnosed malignant diseases among men. It is necessary to search for new methods of additional visualization. The most promising modern diagnostic method is histoscanning (HS) with the software «True Targeting», which allows you to perform «targeted» prostate biopsy (PB) in real time. We conducted a comparative observational clinical study with anonymous Internet survey implemented based on the SurveyMonkey program. Material and methods. The survey of urology specialists was initiated from the beginning of the «Moscow program for «Histoffusion» biopsies». The survey was composed of 16 questions. Data were obtained and analyzed on the doctor's work experience, experience in performing pancreatic biopsy, hospital, features of the operation, method of choosing anesthesia, patient position and complications in the postoperative period. Results. The division by hospitals showed that transrectal prostate biopsy is performed under the conditions in one day hospital in 80% of cases. Biopsy takes no more than 19 minutes on average. Half of the respondents had experience about 5 years, and only about 15% about 15 years. About 68% of specialists recommend performing MRI with contrast. However, only 22% of patients perform results. About 16% note the impossibility of performing MRI due to contraindications or other difficulties of the healthcare system. The most common complications are hemospermia and hematuria. In 100% of cases, respondents noted the need to prescribe antibiotic therapy. In 64.9% of cases, doctors note the need for a histoscan-guided prostate biopsy, and 82.1% are sure that in the future it is necessary to standardize the method of performing histoscan-guided prostate biopsy. Conclusion. We note the lack of standardization of histoscan-guided prostate biopsy. We suggest that the results of histoscan-guided prostate biopsy can be improved by developing a standardized follow-up as well as an algorithm aimed at optimizing for each patient.
- 25 March 2024
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 17 (1)
Open AccessMoscow program on histofusion biopsy of the prostate: results of a survey of practicing urologists based on data from a multicenter study.
Introduction. Prostate cancer (PC) is one of the most frequently diagnosed malignant diseases among men. It is necessary to search for new methods of additional visualization. The most promising modern diagnostic method is histoscanning (HS) with the software «True Targeting», which allows you to perform «targeted» prostate biopsy (PB) in real time. We conducted a comparative observational clinical study with anonymous Internet survey implemented based on the SurveyMonkey program. Material and methods. The survey of urology specialists was initiated from the beginning of the «Moscow program for «Histoffusion» biopsies». The survey was composed of 16 questions. Data were obtained and analyzed on the doctor's work experience, experience in performing pancreatic biopsy, hospital, features of the operation, method of choosing anesthesia, patient position and complications in the postoperative period. Results. The division by hospitals showed that transrectal prostate biopsy is performed under the conditions in one day hospital in 80% of cases. Biopsy takes no more than 19 minutes on average. Half of the respondents had experience about 5 years, and only about 15% about 15 years. About 68% of specialists recommend performing MRI with contrast. However, only 22% of patients perform results. About 16% note the impossibility of performing MRI due to contraindications or other difficulties of the healthcare system. The most common complications are hemospermia and hematuria. In 100% of cases, respondents noted the need to prescribe antibiotic therapy. In 64.9% of cases, doctors note the need for a histoscan-guided prostate biopsy, and 82.1% are sure that in the future it is necessary to standardize the method of performing histoscan-guided prostate biopsy. Conclusion. We note the lack of standardization of histoscan-guided prostate biopsy. We suggest that the results of histoscan-guided prostate biopsy can be improved by developing a standardized follow-up as well as an algorithm aimed at optimizing for each patient.
- Open Access
- 18 July 2023
- Published by Rostov State Medical University in Urology Herald
- Vol. 11 (2) , 74-82
Dynamics of inflammatory reaction markers in patients under endourological interventions
Introduction. Urolithiasis is one of the most widespread urological diseases and infectious complications remain one of the most common adverse events after surgical interventions for urolithiasis. Currently, in routine clinical practice in most clinics in the country, for the purpose of postoperative control and detection of infectious complications is used: a clinical blood test with assessment of the dynamics of the blood leukocyte count. Unfortunately, the current edition of the clinical guidelines does not contain recommendations on what indicators of postoperative follow-up examinations the clinician should focus on in order to identify infectious and inflammatory complications. For this reason, the study of the value of other markers of the inflammatory response appears to be an actual task.Objective. To assess the relationship between the dynamics of laboratory markers of infectious-inflammatory complications and the incidence of infectious-inflammatory response after endoscopic stone removal.Materials & methods. The prospective cohort study included 217 patients diagnosed with urolithiasis and underwent surgical removal of stones by endoscopic method. Of total patient numbers, 43 patients underwent ureteroscopy (URS) with lithotripsy, 152 patients underwent percutaneous nephrolithotripsy (PNL), and 22 patients underwent flexible ureterolithotripsy with lithotripsy. An analysis of demographics, clinical parameters and postoperative complications was performed as a descriptive analysis. Patients underwent a standard list of laboratory and instrumental examination methods. The mandatory control of body temperature was carried out t.i.d. daily. Before surgical treatment, indicators of WBC, LYMP, CRP, and ESR content were recorded on the first and second days after surgical treatment.Results. Postoperative fever was recorded in 40 (18.5%) patients. During the postoperative period, an increase in CRP and ESR was observed in both the fever and the normal temperature group, exceeding the reference values on the first day. At the same time, in the fever group (in 40 patients — 18.5%), a significantly higher increase in CRP and ESR was observed (685% vs 323%) for CRP and (146% vs 80%) for ESR. According to the results obtained in our study, CRP and ESR indicators demonstrate the most clinically significant dynamics in patients with postoperative fever, increasing by more than 500% and 100%, respectively.Conclusions. Endoscopic removal of urinary stones is a safe treatment option in patients with sterile urine cultures. After endoscopic stone removal, all patients experience such reactive changes in peripheral blood parameters as: an increase in the level of leukocytes, lymphopenia, an increase in ESR and CRP levels. Indicators of CRP and ESR demonstrate the most clinically indicative dynamics.
- 18 July 2023
- Published by Rostov State Medical University in Urology Herald
- Vol. 11 (2) , 74-82
Open AccessDynamics of inflammatory reaction markers in patients under endourological interventions
Introduction. Urolithiasis is one of the most widespread urological diseases and infectious complications remain one of the most common adverse events after surgical interventions for urolithiasis. Currently, in routine clinical practice in most clinics in the country, for the purpose of postoperative control and detection of infectious complications is used: a clinical blood test with assessment of the dynamics of the blood leukocyte count. Unfortunately, the current edition of the clinical guidelines does not contain recommendations on what indicators of postoperative follow-up examinations the clinician should focus on in order to identify infectious and inflammatory complications. For this reason, the study of the value of other markers of the inflammatory response appears to be an actual task.Objective. To assess the relationship between the dynamics of laboratory markers of infectious-inflammatory complications and the incidence of infectious-inflammatory response after endoscopic stone removal.Materials & methods. The prospective cohort study included 217 patients diagnosed with urolithiasis and underwent surgical removal of stones by endoscopic method. Of total patient numbers, 43 patients underwent ureteroscopy (URS) with lithotripsy, 152 patients underwent percutaneous nephrolithotripsy (PNL), and 22 patients underwent flexible ureterolithotripsy with lithotripsy. An analysis of demographics, clinical parameters and postoperative complications was performed as a descriptive analysis. Patients underwent a standard list of laboratory and instrumental examination methods. The mandatory control of body temperature was carried out t.i.d. daily. Before surgical treatment, indicators of WBC, LYMP, CRP, and ESR content were recorded on the first and second days after surgical treatment.Results. Postoperative fever was recorded in 40 (18.5%) patients. During the postoperative period, an increase in CRP and ESR was observed in both the fever and the normal temperature group, exceeding the reference values on the first day. At the same time, in the fever group (in 40 patients — 18.5%), a significantly higher increase in CRP and ESR was observed (685% vs 323%) for CRP and (146% vs 80%) for ESR. According to the results obtained in our study, CRP and ESR indicators demonstrate the most clinically significant dynamics in patients with postoperative fever, increasing by more than 500% and 100%, respectively.Conclusions. Endoscopic removal of urinary stones is a safe treatment option in patients with sterile urine cultures. After endoscopic stone removal, all patients experience such reactive changes in peripheral blood parameters as: an increase in the level of leukocytes, lymphopenia, an increase in ESR and CRP levels. Indicators of CRP and ESR demonstrate the most clinically indicative dynamics.
- Open Access
- 12 December 2022
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Health Care of the Russian Federation
- Vol. 66 (6) , 549-554
Histoscan-guided targeted biopsy of the prostate
Introduction. Prostate cancer is the second most commonly diagnosed malignant neoplasm in men. The development of technologies requires the study of advanced research methods, an extraordinary, new limited-invasive method for diagnosing cancer - histoscanning of the prostate. Histoscan is an innovative imaging technique that is potent of differentiating between benign and malignant areas within the examined prostate tissue. With the new “True Targeting” software, it is possible to perform a “targeted” biopsy in real time. Purpose. To determine the efficacy and safety of performing histoscan-guided targeted biopsy of the prostate. Materials and methods. The prospective study with the inclusion of data from 2501 patients examined at the Clinic of urology of the Moscow State Medical University named after A.I. Evdokimov at the Municipal Clinical Hospital named after S.I. Spasokukotsky. Results. The average age of the patients was 66 years, the level of prostate specific antigen was about 14,39 ng/ml, the volume of the prostate was 54,43 cm3. The overall incidence of prostate cancer was 53,38%, with a biopsy of 12 points - 52,1%, while with a targeted biopsy- 37,58%. Among the biopsy complications, hemospermia (Clavien-Dindo - I) was most often (33% of cases), hematuria (Clavien-Dindo - I-II) in 15% of cases. No serious complications were identified. Limitations. As restrictions, the following were identified: prostate biopsy-subject, 2501 patients - a quantitative parameter, patients with suspected prostate cancer - a qualitative indicator. Conclusion. The published results of the study showed that histoscan-guided biopsy ofthe prostate is safe, effective, and therefore has alarge potential in cancer diagnosis, as it helps both in choosing a treatment method and in planning the course of further surgery.
- 12 December 2022
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Health Care of the Russian Federation
- Vol. 66 (6) , 549-554
Open AccessHistoscan-guided targeted biopsy of the prostate
Introduction. Prostate cancer is the second most commonly diagnosed malignant neoplasm in men. The development of technologies requires the study of advanced research methods, an extraordinary, new limited-invasive method for diagnosing cancer - histoscanning of the prostate. Histoscan is an innovative imaging technique that is potent of differentiating between benign and malignant areas within the examined prostate tissue. With the new “True Targeting” software, it is possible to perform a “targeted” biopsy in real time. Purpose. To determine the efficacy and safety of performing histoscan-guided targeted biopsy of the prostate. Materials and methods. The prospective study with the inclusion of data from 2501 patients examined at the Clinic of urology of the Moscow State Medical University named after A.I. Evdokimov at the Municipal Clinical Hospital named after S.I. Spasokukotsky. Results. The average age of the patients was 66 years, the level of prostate specific antigen was about 14,39 ng/ml, the volume of the prostate was 54,43 cm3. The overall incidence of prostate cancer was 53,38%, with a biopsy of 12 points - 52,1%, while with a targeted biopsy- 37,58%. Among the biopsy complications, hemospermia (Clavien-Dindo - I) was most often (33% of cases), hematuria (Clavien-Dindo - I-II) in 15% of cases. No serious complications were identified. Limitations. As restrictions, the following were identified: prostate biopsy-subject, 2501 patients - a quantitative parameter, patients with suspected prostate cancer - a qualitative indicator. Conclusion. The published results of the study showed that histoscan-guided biopsy ofthe prostate is safe, effective, and therefore has alarge potential in cancer diagnosis, as it helps both in choosing a treatment method and in planning the course of further surgery.
- Open Access
- 15 December 2021
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 23 (6) , 578-585
Results of a clinical study of the drug efficacy and safety for intravesical administration based on bacteriophages in therapy in patients with chronic recurrent cystitis
Background. Urinary tract infections remain one of the urgent problems in the aspect of qualified medical care. The causative agents of nosocomial infections are becoming more and more resistant to the drugs used, while the rate of new drugs synthesis is lower than the rate of development of antibiotic resistance. Routine and empirical prevention of recurrent urinary tract infections is often ineffective. Aim. To study the efficacy and safety of intravesical application of the drug based on bacteriophages in therapy in patients with chronic recurrent cystitis. Materials and methods. A clinical study was carried out to study the efficacy and safety of the drug for intravesical administration based on bacteriophages in therapy in patients with chronic recurrent cystitis. The study included 75 patients who were divided into 3 groups in a 1: 1: 1 ratio. In the main group, the drug for intravesical administration based on bacteriophages, as well as rectal suppositories with bacteriophages were used; in the control group only a drug for intravesical administration based on bacteriophages or rectal suppositories with bacteriophages. On visits 1-4, all patients underwent a clinical blood test, general urine analysis, bacteriological urine analysis, as well as urine analysis by the polymerase chain reaction method. The analysis of the patients condition in groups was carried out according to the dynamics of main clinical symptoms changes, data from validated scales for assessing pelvic pain and urgency/frequency of urination and assessment of symptoms of acute cystitis (Acute Cystitis Symptom Score ACSS), as well as the dynamics of changes in objective parameters of laboratory studies and possible changes in sensitivity uropathogens to antibacterial drugs. Results. The average age of the patients included in the study was 50.6 years. In all 3 groups, bacteriological examination of urine showed a predominant growth of Escherichia coli (3104 CFU/ml). In the course of the study, there was a good tolerance to therapy, a decrease in clinical symptoms, as well as a significant decrease in the total score according to the pelvic pain scale and urgency/frequency of urination and the ACSS scale in all patients. Conclusion. The emergence of a large number of microorganisms resistant to various antibiotics and their rapid spread in the environment has led to an increase in scientific interest in bacteriophage therapy as an alternative method of treatment. The overall subjective effectiveness of the therapy in our study was more than 80%, safety - 100%. Further research will allow for a personalized approach to the treatment of infectious diseases of the urinary system.
- 15 December 2021
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 23 (6) , 578-585
Open AccessResults of a clinical study of the drug efficacy and safety for intravesical administration based on bacteriophages in therapy in patients with chronic recurrent cystitis
Background. Urinary tract infections remain one of the urgent problems in the aspect of qualified medical care. The causative agents of nosocomial infections are becoming more and more resistant to the drugs used, while the rate of new drugs synthesis is lower than the rate of development of antibiotic resistance. Routine and empirical prevention of recurrent urinary tract infections is often ineffective. Aim. To study the efficacy and safety of intravesical application of the drug based on bacteriophages in therapy in patients with chronic recurrent cystitis. Materials and methods. A clinical study was carried out to study the efficacy and safety of the drug for intravesical administration based on bacteriophages in therapy in patients with chronic recurrent cystitis. The study included 75 patients who were divided into 3 groups in a 1: 1: 1 ratio. In the main group, the drug for intravesical administration based on bacteriophages, as well as rectal suppositories with bacteriophages were used; in the control group only a drug for intravesical administration based on bacteriophages or rectal suppositories with bacteriophages. On visits 1-4, all patients underwent a clinical blood test, general urine analysis, bacteriological urine analysis, as well as urine analysis by the polymerase chain reaction method. The analysis of the patients condition in groups was carried out according to the dynamics of main clinical symptoms changes, data from validated scales for assessing pelvic pain and urgency/frequency of urination and assessment of symptoms of acute cystitis (Acute Cystitis Symptom Score ACSS), as well as the dynamics of changes in objective parameters of laboratory studies and possible changes in sensitivity uropathogens to antibacterial drugs. Results. The average age of the patients included in the study was 50.6 years. In all 3 groups, bacteriological examination of urine showed a predominant growth of Escherichia coli (3104 CFU/ml). In the course of the study, there was a good tolerance to therapy, a decrease in clinical symptoms, as well as a significant decrease in the total score according to the pelvic pain scale and urgency/frequency of urination and the ACSS scale in all patients. Conclusion. The emergence of a large number of microorganisms resistant to various antibiotics and their rapid spread in the environment has led to an increase in scientific interest in bacteriophage therapy as an alternative method of treatment. The overall subjective effectiveness of the therapy in our study was more than 80%, safety - 100%. Further research will allow for a personalized approach to the treatment of infectious diseases of the urinary system.
- Open Access
- 10 November 2021
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 17 (3) , 121-128-128
Long-term oncological and functional results of robot-assisted radical prostatectomy
Prostate cancer (РСа), being one of the leading causes of cancer mortality in men in Russia and in a number of other countries of the world, remains an urgent problem for modern oncourology, and the choice of surgical method is an important task for a surgeon. Such a pronounced interest in robot-assisted radical prostatectomy (RARP) in patients is driven by good tolerance and effectiveness of these surgical interventions, despite the fact that radical prostatectomy is considered to be the "gold standard" for treatment of patients with clinically localized РСа with regard to European Association of Urology data. The long-term oncological and functional results and the quality of life of patients after RARP deserve close attention and thorough study. According to the data presented in this article, it is obvious that RARP is the preferred method for surgical treatment of РСа, since oncological and functional results in the long-term follow-up are comparable to the results after radical prostatectomy, and according to some authors, these results are superior to the results of radical prostatectomy. The results of the study will allow to continue further introduction of RARP into clinical practice and its popularization as a method of surgical treatment of patients with localized PCa, which will reduce the length of hospital stay of patients, accelerate their medical and social rehabilitation, and improve the quality of medical care.The amount of data on the study of distant oncological and functional results of RARP as well as its superiority over other treatment methods is limited in medical literature, which prompted us to conduct our own research. Currently the urological clinic of the A.I. Evdokimov Moscow State University of Medicine and Dentistry continues work aimed at studying the longterm results of RARP in the first patients in Russia.
- 10 November 2021
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 17 (3) , 121-128-128
Open AccessLong-term oncological and functional results of robot-assisted radical prostatectomy
Prostate cancer (РСа), being one of the leading causes of cancer mortality in men in Russia and in a number of other countries of the world, remains an urgent problem for modern oncourology, and the choice of surgical method is an important task for a surgeon. Such a pronounced interest in robot-assisted radical prostatectomy (RARP) in patients is driven by good tolerance and effectiveness of these surgical interventions, despite the fact that radical prostatectomy is considered to be the "gold standard" for treatment of patients with clinically localized РСа with regard to European Association of Urology data. The long-term oncological and functional results and the quality of life of patients after RARP deserve close attention and thorough study. According to the data presented in this article, it is obvious that RARP is the preferred method for surgical treatment of РСа, since oncological and functional results in the long-term follow-up are comparable to the results after radical prostatectomy, and according to some authors, these results are superior to the results of radical prostatectomy. The results of the study will allow to continue further introduction of RARP into clinical practice and its popularization as a method of surgical treatment of patients with localized PCa, which will reduce the length of hospital stay of patients, accelerate their medical and social rehabilitation, and improve the quality of medical care.The amount of data on the study of distant oncological and functional results of RARP as well as its superiority over other treatment methods is limited in medical literature, which prompted us to conduct our own research. Currently the urological clinic of the A.I. Evdokimov Moscow State University of Medicine and Dentistry continues work aimed at studying the longterm results of RARP in the first patients in Russia.
- Open Access
- 9 July 2020
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 22 (3) , 42-48
The experience of using a bacteriophages-based complex antibacterial and analgesic drug in gel formulation in women who underwent various instrumental and diagnostic and treatment interventions
During the spread of bacterial infections with extensive drug resistance, the potential of existing antibacterial drugs is significantly reduced. The medical community is seeking opportunities for the rational use of antibacterial drugs, the development of new drugs, as well as the use of alternative treatments for these infections. Aim. The objective of this study was to evaluate the effectiveness of the use of a complex antibacterial and analgesic drug based on bacteriophages in gel form during various instrumental studies and diagnostic procedures in order to minimize the risk of the urinary system infections complications. Materials and methods. The study included 235 women aged 18 to 75 years who underwent treatment at the Moscow State Clinical Hospital named after Spasokukotsky and in the clinic of urology of Moscow State University of Medicine and Dentistry from September 2019 to January 2020. During the manipulation, all patients of the main group (n=120) used a developed preparation based on bacteriophages, and in the control group (n=115), a topical gel based on chlorhexidine dihydrochloride and lidocaine hydrochloride was used. All patients before the manipulation, as well as 10 days after the manipulation, underwent bacteriological analysis of urine. Efficiency assessment was carried out on the basis of laboratory data obtained, as well as according to the visual analogue scale of the pain syndrome severity. Results. None of the patients in the main group showed intolerance, side effects and allergic reactions of the developed drug based on bacteriophages. Bacteriological analysis of urine received before manipulation in both groups showed the absence of clinically significant titers of pathogenic bacteria, while 1 week after manipulation the number of titers of pathogenic bacteria (104) was significantly higher in the control group (p0.04). In patients of the main group, the incidence of dysuria was lower compared with the control group (p0.05). Conclusion. The study showed good tolerance of the developed drug and its clinical effectiveness in reducing the number of symptomatic bacteriuria; severity of pain after undergoing manipulation was relatively lower in the main group of patients. Conducting multicenter studies with the inclusion of a larger number of patients in the future will reduce the economic costs associated with treating patients by reducing the number of cases of nosocomial infections and reducing postoperative time spent by patients in the hospital.
- 9 July 2020
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 22 (3) , 42-48
Open AccessThe experience of using a bacteriophages-based complex antibacterial and analgesic drug in gel formulation in women who underwent various instrumental and diagnostic and treatment interventions
During the spread of bacterial infections with extensive drug resistance, the potential of existing antibacterial drugs is significantly reduced. The medical community is seeking opportunities for the rational use of antibacterial drugs, the development of new drugs, as well as the use of alternative treatments for these infections. Aim. The objective of this study was to evaluate the effectiveness of the use of a complex antibacterial and analgesic drug based on bacteriophages in gel form during various instrumental studies and diagnostic procedures in order to minimize the risk of the urinary system infections complications. Materials and methods. The study included 235 women aged 18 to 75 years who underwent treatment at the Moscow State Clinical Hospital named after Spasokukotsky and in the clinic of urology of Moscow State University of Medicine and Dentistry from September 2019 to January 2020. During the manipulation, all patients of the main group (n=120) used a developed preparation based on bacteriophages, and in the control group (n=115), a topical gel based on chlorhexidine dihydrochloride and lidocaine hydrochloride was used. All patients before the manipulation, as well as 10 days after the manipulation, underwent bacteriological analysis of urine. Efficiency assessment was carried out on the basis of laboratory data obtained, as well as according to the visual analogue scale of the pain syndrome severity. Results. None of the patients in the main group showed intolerance, side effects and allergic reactions of the developed drug based on bacteriophages. Bacteriological analysis of urine received before manipulation in both groups showed the absence of clinically significant titers of pathogenic bacteria, while 1 week after manipulation the number of titers of pathogenic bacteria (104) was significantly higher in the control group (p0.04). In patients of the main group, the incidence of dysuria was lower compared with the control group (p0.05). Conclusion. The study showed good tolerance of the developed drug and its clinical effectiveness in reducing the number of symptomatic bacteriuria; severity of pain after undergoing manipulation was relatively lower in the main group of patients. Conducting multicenter studies with the inclusion of a larger number of patients in the future will reduce the economic costs associated with treating patients by reducing the number of cases of nosocomial infections and reducing postoperative time spent by patients in the hospital.